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e123and the intensity or
ptoms hearing loss,
tinnitus, and aural fullness. The duration of the disease
significantly correlated with the extent of both cochlear and
vestibular hydrops, but not with the number of definite
vertigo days.
Conclusion: The ELH was progressive in the long-term course
of the disease in this large population of definite MD patients,
but short-term and middle-term fluctuations of the symptom
severity did not involve measurable variations of the ELH.
Furthermore, the symptom severity did not decrease with
increasing disease duration. Key Words: Endolymphatic
hydrops—LEIM—Menière’s disease—Menière’s symptoms.Otol Neurotol 39:e123–e130, 2018.(MD) is a disorder of the inner ear route of contrast agent application. TMenière’s disease
which is characterized by attacks of vertigo, tinnitus, and
cochlear hearing loss. Clinical diagnosis of MD has been
based on the AAO-HNS Guidelines 1995 (1). In 2015, a
modification of these diagnostic criteria was presented by
the Classification Committee of the Barany Society, which
redefined the two MD categories ‘‘definite’’ and ‘‘proba-
ble’’ (2,3). The histopathologic hallmark of MD is an
excess of fluid in the endolymph space of the inner ear (4),
even though the role of endolymphatic hydrops (ELH)
in the pathophysiology of the disease remains unclear.
Recently, magnetic resonance imaging (MRI) has been
used to visualize endolymphatic hydrops in MD patients in
vivo, using the intratympanic (5,6) or the intravenous (7)his method enables
diagnostic certainty which hitherto could only be achieved
by histological postmortem examination (1), and has been
used to improve differential diagnosis between MD and
vestibular migraine (8,9), to revise the clinical classifica-
tion of hydropic ear disease (10), and to introduce new
diagnostic functional test methods for MD (11). Further-
more, inner ear MRI allows for quantitative assessment of
endolymphatic hydrops.
Previous studies investigating the impact of the extent
of endolymphatic hydrops on audiovestibular function
tests have shown a correlation between the degree of
endolymphatic hydrops and the degree of hearing loss
and a trend toward a correlation between the degree of
endolymphatic hydrops and canal paresis measured by
caloric irrigation (6,12,13). It is, however, not yet clear in
which way the degree of endolymphatic hydrops affects
the severity of patients’ symptoms. In this prospective
observational study, we therefore recorded the occur-
rence and intensity of vertigo attacks and coexisting aural
symptoms by the use of patient diaries in a large popula-
tion of Menière’s patients and analyzed the degree of
cochlear and vestibular endolymphatic hydrops by the
use of inner ear MRI.horized reproduction of this article is prohibited.
FIG. 1. Locally enhanced inner ear MR imaging with evi-
dence of no (A), mild (B), marked (C), and extreme (D)
endolymphatic hydrops. Bright areas represent the contrast-
enhanced perilymphatic space, dark areas within the inner ear
represent the endolymphatic space. MR indicates magnetic
resonance.
TABLE 1. Characteristics of the study population (n¼ 192)
Male/Female 104/88
Age (y) 54.3 15.3 (range 15–79)




Disease duration (mo) 123 122 (range 4–700)
Pure tone average 0.5–3 kHz (dB) 48.4 26.3 (range 6–130)
Caloric test canal paresis (%) 22.3 31.2 (range 0–100)
Vertigo days per month 3.7 5.8 (range 0–31)
Vertigo days per week 1.0 1.7 (range 0–7)
Staging was based on the pure-tone average at 0.5–3 kHz (AAO-
HNS 1995).
Values are expressed as meanSD.
e124 C. JERIN ET AL.The aim of this study was to characterize the short-,
middle-, and long-term occurrence of vertigo attacks in
Menière’s disease and to investigate the relationship




The study was conducted at a large tertiary referral center for
vestibular disorders. One hundred ninety-two consecutive
patients with clinically definite MD (according to the AAO-
HNS 1995 criteria) who underwent locally enhanced inner ear
MRI (LEIM) in the 5-year period from 2011 to 2015 partici-
pated in this study (104 male/ 88 female, mean age¼ 54.3 y, age
range¼ 15–79 y). These patients represented an average pop-
ulation of Menière’s patients including different MD stages.
Clinical characteristics of the study population are summarized
in Table 1. Endolymphatic hydrops were visualized by LEIM
after intratympanic application of contrast agent as previously
described (6). Grading of the severity of cochlear and vestibular
ELH on a scale of 0 to 3 was performed as described previously
(6): 0: no hydrops, 1: mild hydrops, 2: marked hydrops, 3:
extreme hydrops. Exemplary MR images are shown in Figure 1.
One day before LEIM, all the patients underwent audiometry
and caloric irrigation. Audiometry results (pure-tone average)
represent the arithmetic mean of hearing thresholds at 0.5, 1, 2,
and 3 kHz. Caloric irrigation was evaluated on the basis of the
degree of canal paresis (%) according to the Jongkee’s formula.
The study protocol was approved by the institutional review
board (Protocol No. 210–12) and all subjects gave written
informed consent before participation in the study.
Record of Symptom Severity
All the participants were instructed to keep a daily vertigo
diary to document occurrence and intensity of MD attacks, as
described previously (14,15). Intensity of vertigo was measured
on a five-point scale ranging from zero (no vertigo) to four
(worst vertigo ever): 0: vertigo-free day, 1: day with a mild
attack, 2: moderately severe attacks lasting more than 20
minutes, 3: severe attacks lasting an hour or more or accompa-
nied by nausea or vomiting, 4: worst attack ever experienced. A
definite vertigo day was defined as any day with a vertigo
severity score of two or higher. Vertigo diaries were recorded
by the participants for the 3-month period 2 months beforeCopyright © 2017 Otology & Neurotology, Inc. Unauthorized reproduction of this article is prohibited.
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FIG. 2. Relationship between the grade of endolymphatic hydrops and pure-tone average hearing levels at 0.5, 1, 2, and 3 kHz. The
correlation is highly significant for both cochlear and vestibular ELH ( p<0.01). Horizontal bars represent the median. ELH indicates
endolymphatic hydrops.
ELH AND SYMPTOMS IN MENIÈRE’S DISEASE e125LEIM until 1 month after LEIM. Furthermore, patients were
instructed to keep a more detailed and comprehensive symptom
diary for the 2-week period 1 week before LEIM until 1 week
after LEIM. In addition to the occurrence and intensity of MD
attacks, the intensity of hearing loss, tinnitus, and aural fullness
were documented in these symptom records by the use of a five-
point scale ranging from zero to four, analogous to vertigo
severity. To analyze not only the absolute symptom load, but
also the symptom fluctuation as a marker of disease activity,
fluctuation of symptoms was quantified by adding up the
increase of severity scores from day to day during the 2-week
period. In this way, fluctuation scores were calculated for
vertigo, hearing loss, tinnitus, and aural fullness.
Data Analysis
Data analysis was performed with IBM SPSS Statistics 23
(SPSS Inc., Chicago, IL). The data were tested for normal
distribution with the Kolmogorov–Smirnov test. Correlations
between the degree of ELH, the number of definite vertigo days,
fluctuation scores, disease duration, and audiovestibular func-
tion tests were calculated using the Spearman’s rank correlation
coefficient for nonparametric variables. Statistical significance
was determined at the p< 0.05 level.
RESULTS
Cochlear hydrops was found in 175 patients. Sixty-
three patients were classified as cochlear hydrops gradeCopyright © 2017 Otology & Neurotology, Inc. Unaut
FIG. 3. Relationship between the grade of endolymphatic hydrops a
irrigation. There was no significant correlation. Horizontal bars represe1, 75 patients as grade 2, and 37 patients as grade 3.
Vestibular hydrops was detected in 161 patients. Fifty
patients had vestibular hydrops grade 1, 60 patients grade
2, and 51 patients grade 3. There was a highly significant
correlation between both cochlear and vestibular ELH
and PTA (rho¼ 0.444, p< 0.001 and rho¼ 0.536,
p< 0.001, respectively) (Fig. 2), but not between
cochlear and vestibular ELH and caloric irrigation canal
paresis ( p¼ 0.12 and p¼ 0.14, respectively) (Fig. 3).
Effects of Short-term Symptom Severity
The 2-week symptom diary served as short-term mea-
sure of symptom severity and fluctuation. On average,
patients experienced 1.0 definite vertigo days per week in
this period. There was no significant correlation between
the number of definite vertigo days per week and the
extent of cochlear or vestibular hydrops ( p¼ 0.60 and
p¼ 0.06, respectively) (Fig. 4). There was also no corre-
lation between the extent of cochlear or vestibular
hydrops and the intensity of the coexisting aural symp-
toms hearing loss, tinnitus, and aural fullness ( p¼ 0.84,
0.65, 0.67 and p¼ 0.85, 0.58, 0.48, respectively). Fur-
thermore, neither cochlear nor vestibular hydrops corre-
lated with the fluctuation of vertigo, hearing loss,
tinnitus, and aural fullness ( p¼ 0.65, 0.72, 0.86, 0.07
and p¼ 0.08, 0.91, 0.65, 0.60, respectively) (Fig. 5).horized reproduction of this article is prohibited.
nd horizontal semicircular canal paresis determined on caloric
nt the median.
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FIG. 4. Relationship between the grade of cochlear and vestibular hydrops and the number of vertigo days per week during the short-time
2-week period. There was no significant correlation. Horizontal bars represent the median.
e126 C. JERIN ET AL.Effects of Middle-term Symptom Severity
As regards the middle-term symptom severity, the
occurrence of vertigo attacks was documented for the
3-month period 2 months before LEIM until 1 month
after LEIM. The average number of definite vertigo days
per month amounted to 3.7. There was no significant
correlation between the number of monthly definite
vertigo days and the extent of cochlear or vestibular
hydrops ( p¼ 0.94 and p¼ 0.36, respectively) (Fig. 6).
Furthermore, there was no correlation between monthly
definite vertigo days and the caloric test canal paresis
( p¼ 0.34). There was, however, a nonsignificant trend
toward poorer audiometry results with a higher number
of monthly definite vertigo days ( p¼ 0.07).
Long-term Effects
The duration of the disease, i.e., the time period since
the onset of audiovestibular symptoms, ranged between 4
and 700 months (average 10.3 y). There was a significant
correlation between the duration of the disease and the
extent of both cochlear and vestibular hydrops
(rho¼ 0.174, p¼ 0.03 and rho¼ 0.267, p¼ 0.001)
(Fig. 7), as well as between disease duration on the
one hand and audiometry on the other hand (rho¼ 0.278,
0.278, p< 0.001). There was no correlation between the
duration of the disease and caloric irrigation ( p¼ 0.24) or
between the duration of the disease and the number of
monthly definite vertigo days ( p¼ 0.43) (Fig. 8).
DISCUSSION
Until a couple of years ago, the diagnosis Menière’s
disease was reliant on clinical criteria and the exclusion
of differential diagnoses. These criteria, however, imply
diagnostic uncertainty in patients who do not present with
the typical symptom complex. Indeed, symptoms may
distinctly vary in severity, particularly in the early stagesCopyright © 2017 Otology & Neurotology, Inc. Unauthorized
Otology & Neurotology, Vol. 39, No. 2, 2018of the disease (16). MRI-based visualization of endolym-
phatic hydrops after intratympanic or—because of the
simpler procedure more readily available—intravenous
application of contrast agent does not only allow for
certain diagnosis of MD, but also for quantitative assess-
ment and grading of endolymphatic hydrops. Over the
last 10 years, since the first report by Nakashima et al. (5)
in Japan, this method has been practiced in a variety of
countries worldwide, including (but not limited to!)
Finland, Germany, Italy, Switzerland, the United States,
Australia, China, France, Spain (17–22). Of interest, a
large multicenter study confirmed that, if examined by
inner ear MRI, all patients fulfilling the 1995 AAO-HNS-
criteria (1) of ‘‘definite MD’’ show evidence of endo-
lymphatic hydrops (16).
Previously, MRI has been used to investigate whether
the degree of ELH affects audiovestibular function tests.
A couple of studies have shown a correlation between the
extent of ELH and the degree of hearing loss and a trend
toward a correlation between the extent of ELH and
caloric irrigation canal paresis (6,12,13). Consistent with
these reports, there was a highly significant correlation
between cochlear and vestibular ELH and PTA in our
study cohort. However, there was no significant correla-
tion between ELH and canal paresis, further supporting
that auditory function deteriorates with increasing ELH,
whereas there is no conclusive relationship between ELH
and canal paresis. Other vestibular function tests like
video head impulse testing, rotatory chair testing, and
vestibular evoked myogenic potentials might be more
strongly associated with MRI evidence of hydrops but
have not been performed in our patient population.
Furthermore, we observed a highly significant corre-
lation between the extent of cochlear and vestibular ELH
and the duration of the disease, which supports the
assumption that ELH progresses in the course of the
disease. Evidence for a progression of ELH over time has reproduction of this article is prohibited.
FIG. 5. Relationship between the grade of cochlear and vestibular hydrops and the fluctuation of vertigo, hearing loss, tinnitus, and aural
fullness during the short-time 2-week period. There was no significant correlation. Horizontal bars represent the median.
ELH AND SYMPTOMS IN MENIÈRE’S DISEASE e127previously been provided by studies showing a relation-
ship between the disease duration and the degree of ELH
(6,13) and a study showing an enlargement of ELH in a
single individual in the course of 2 years (23).Copyright © 2017 Otology & Neurotology, Inc. UnautThe duration of the disease, however, did not corre-
late with the number of monthly vertigo days, so that
we did not observe any effect of disease duration
on the frequency of vertigo attacks. This lack ofhorized reproduction of this article is prohibited.
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FIG. 7. Relationship between the grade of endolymphatic hydrops and the duration of the disease. The correlation is significant for both
cochlear and vestibular ELH ( p¼0.03 and p<0.01). Horizontal bars represent the median. ELH indicates endolymphatic hydrops.
FIG. 6. Relationship between the grade of cochlear and vestibular hydrops and the number of vertigo days per month during the middle-
time 3-month period. There was no significant correlation. Horizontal bars represent the median.
FIG. 8. Relationship between the duration of the disease and the
number of monthly vertigo days. There was no significant correlation.
e128 C. JERIN ET AL.association contradicts previous assumptions that ver-
tiginous episodes might improve or even resolve in the
course of the disease (24,25), which have led to the
presumptive concept of so-called ‘‘burning out’’ of
MD. In contrast, it supports evidence that frequency
and intensity of vertigo symptoms do not depend on the
disease duration and that patients frequently even
experience an increase of vertigo severity after long-
standing disease (26).
To date, it is not known how the degree of endo-
lymphatic hydrops affects patients’ symptoms. Previ-
ous studies using the inner ear MRI to visualize ELH in
smaller populations of Menière’s patients found no
relationship between ELH and the frequency of vertigo
attacks in the months before the MRI or between
hydrops and other aural symptoms such as hearing
loss, tinnitus, and aural fullness (13,27). To the best
of our knowledge, however, this is the first study
providing data from detailed symptom diaries includ-
ing the occurrence and fluctuation of vertigo and
concomitant aural symptoms during a short- and mid-
dle-term period in a large population of definite
Menière’s disease patients.Copyright © 2017 Otology & Neurotology, Inc. Unauthorized
Otology & Neurotology, Vol. 39, No. 2, 2018We did not observe any relationship between the
extent of ELH and the frequency of vertigo attacks
neither with regard to the short-term 2-week period nor
with regard to the middle-term 3-month period. The
severity and activity of concomitant aural symptoms
were not reflected in the ELH grade, either. Short-term
and middle-term fluctuations of the symptom severity reproduction of this article is prohibited.
5. Nakashima T, Naganawa S, Sugiura M, et al. Visualization of
ELH AND SYMPTOMS IN MENIÈRE’S DISEASE e129thus do not seem to involve measurable variations of
the ELH, even though the ELH progresses in the long-
term course of Menière’s disease. The lack of ELH
fluctuations measurable by MRI, however, does not
imply that the extent of ELH does not influence
Menière’s symptoms. The resolution provided by the
MRI might be too low to provide visualization of slight
ELH fluctuations. In other words, the slight fluctua-
tions in ELH severity which possibly occur within a
time frame of days to months may very well be of a
magnitude below the resolution capacity of MR imag-
ing. It has to be kept in mind that the normal total
endolymph volume amounts to as little as 50 ml. Like-
wise, the endolymphatic duct of the semicircular canals
is—due to its slim dimensions—not visible on MRI, in
the healthy state as well as in the diseased hydropic
state.
Short-term and middle-term fluctuations of the
symptom severity do not entail measurable variations
of the ELH. This might also implicate that there are
no measurable ELH variations in the context of short-
or middle-term therapeutic interventions and might
provide an explanation why previous studies using
inner ear MRI failed to show a reduction of the
ELH following treatment of Menière’s patients with
betahistine, frusemide, or gentamicin (28–30). These
observations should be taken into consideration by
future studies investigating the effect of therapeutic
interventions on the ELH measured by inner ear MRI.
CONCLUSION
In this large population of definite MD patients, the
endolymphatic hydrops progresses in the long-term
course of Menière’s disease. Hearing loss deteriorates
with increasing ELH. Short-term and middle-term fluc-
tuations of the symptom severity, in contrast, do not seem
to involve measurable variations of the ELH. Further-
more, the symptom severity does not decrease with
increasing disease duration.
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